TR199800517A3 - Hümanize anti-hümen fas antikor. - Google Patents

Hümanize anti-hümen fas antikor.

Info

Publication number
TR199800517A3
TR199800517A3 TR1998/00517A TR9800517A TR199800517A3 TR 199800517 A3 TR199800517 A3 TR 199800517A3 TR 1998/00517 A TR1998/00517 A TR 1998/00517A TR 9800517 A TR9800517 A TR 9800517A TR 199800517 A3 TR199800517 A3 TR 199800517A3
Authority
TR
Turkey
Prior art keywords
humanized anti
fas antibody
human fas
human
antibody
Prior art date
Application number
TR1998/00517A
Other languages
English (en)
Other versions
TR199800517A2 (tr
Inventor
Serizawa Nobufusa
Haruyama Hideyuki
Takahashi Tohru
Nakahara Kaori
Yonehara Shin
Original Assignee
Sankyo Company Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Company Limited filed Critical Sankyo Company Limited
Publication of TR199800517A2 publication Critical patent/TR199800517A2/tr
Publication of TR199800517A3 publication Critical patent/TR199800517A3/tr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2878Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
TR1998/00517A 1997-03-21 1998-03-20 Hümanize anti-hümen fas antikor. TR199800517A3 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6793897 1997-03-21

Publications (2)

Publication Number Publication Date
TR199800517A2 TR199800517A2 (tr) 1998-10-21
TR199800517A3 true TR199800517A3 (tr) 1998-10-21

Family

ID=13359383

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/00517A TR199800517A3 (tr) 1997-03-21 1998-03-20 Hümanize anti-hümen fas antikor.

Country Status (15)

Country Link
EP (1) EP0866131A3 (tr)
KR (1) KR19980080514A (tr)
AR (1) AR012148A1 (tr)
AU (1) AU736287B2 (tr)
BR (1) BR9800937A (tr)
CA (1) CA2232828A1 (tr)
CZ (1) CZ85898A3 (tr)
HU (1) HUP9800613A3 (tr)
ID (1) ID20065A (tr)
IL (1) IL123756A0 (tr)
NO (1) NO981272L (tr)
NZ (1) NZ330004A (tr)
PL (1) PL325457A1 (tr)
TR (1) TR199800517A3 (tr)
ZA (1) ZA982371B (tr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6972323B1 (en) 1997-04-01 2005-12-06 Sankyo Company, Limited Anti-Fas antibodies
DE69938451T2 (de) 1998-06-18 2009-04-09 Imed Ab Fas peptide und antikörper zur modulierung von apoptosis
AU757961B2 (en) * 1998-09-30 2003-03-13 Sankyo Company Limited Anti-Fas antibodies
DE60003632T2 (de) * 1999-01-11 2004-04-15 Leadd B.V. Verwendung von apoptose-induzierende mittel zur herstellung eines mittels zur behandlung von (auto)immunkrankheiten
AU2004233486B2 (en) * 1999-01-11 2007-09-13 Leadd B.V. Use of apoptosis inducing agents in the treatment of (auto)immune diseases
HUP0201333A3 (en) 1999-05-24 2004-11-29 Sankyo Company Ltd Chuo Ku Medicinal compositions containing anti-fas antibody
ATE482719T1 (de) * 2002-02-21 2010-10-15 Univ Duke Behandlungsverfahren unter verwendung von anti- cd22-antikörpern
AU2003234003A1 (en) * 2002-05-17 2003-12-02 Fusion Antibodies Limited Treatment of cancer by the use of anti fas antibody
GB0306618D0 (en) * 2003-03-22 2003-04-30 Univ Newcastle Antibody
EP2650306A1 (en) 2006-03-06 2013-10-16 Aeres Biomedical Limited Humanized Anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
US8030026B2 (en) * 2009-02-24 2011-10-04 Abbott Laboratories Antibodies to troponin I and methods of use thereof
CA3004830A1 (en) 2015-11-11 2017-05-18 Opi Vi- Ip Holdco Llc Composition and methods for anti-tnfr2 antibodies

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL162181A (en) * 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
US6407213B1 (en) * 1991-06-14 2002-06-18 Genentech, Inc. Method for making humanized antibodies
CA2174132A1 (en) * 1993-10-14 1995-04-20 Immunex Corporation Fas antagonists and uses thereof
CA2158822C (en) * 1994-09-27 2008-12-23 Kusuki Nishioka Therapeutic agent for rheumatic disease
AU724579B2 (en) * 1996-04-01 2000-09-28 Sankyo Company Limited Anti-Fas recombinant antibodies and DNA therefor

Also Published As

Publication number Publication date
EP0866131A2 (en) 1998-09-23
PL325457A1 (en) 1998-09-28
TR199800517A2 (tr) 1998-10-21
KR19980080514A (ko) 1998-11-25
AU736287B2 (en) 2001-07-26
AR012148A1 (es) 2000-09-27
CA2232828A1 (en) 1998-09-21
NO981272L (no) 1998-09-22
HUP9800613A2 (hu) 1999-02-01
HU9800613D0 (en) 1998-05-28
NO981272D0 (no) 1998-03-20
CZ85898A3 (cs) 1998-10-14
IL123756A0 (en) 1998-10-30
NZ330004A (en) 1998-10-28
ID20065A (id) 1998-09-24
EP0866131A3 (en) 1999-12-15
HUP9800613A3 (en) 2001-04-28
AU5937598A (en) 1998-10-15
BR9800937A (pt) 2000-01-11
ZA982371B (en) 1998-09-28

Similar Documents

Publication Publication Date Title
DK1516629T3 (da) Humaniseret anti-CD-11a antibodies
DE69920897D1 (de) Monoklonale antikörper mit verringerter immunisierungsfähigkeit
TR199501614A2 (tr) Anti-alfa integrin monoklonal antikor.
IS8950A (is) Einklóna mótefni gegn CTLA-4 úr manni.
CY2007012I2 (el) Αντισωματα anti-vegf
DE69935516D1 (de) Antikörper mit verbesserter produzierbarkeit
EE200300179A (et) Humaniseeritud LT-ß-R-i vastased antikehad
EE200000470A (et) Inimese CD40-vastased antikehad
EP1071458A4 (en) HUMANIZED ANTIBODIES AND ITS USES
IL147517A0 (en) Monoclonal antibodies and immunoassay utilizing the same
DE69828154D1 (de) Anti-alphavbeta3 humanizierte monoklonale antikörper
TR199800517A3 (tr) Hümanize anti-hümen fas antikor.
DE69738312D1 (de) Hepatitis b monoklonale antikörper
AU7072998A (en) Immunoassays using anti-allotypic monoclonal antibodies
TR199800604A3 (tr) Anti-fas antikorlari.
DE69023717D1 (de) Monoklonaler Antikörper.
BR1100555B1 (pt) anticorpos monoclonais humanizados.
ITRM920223A0 (it) Anticorpi monoclonali anti-idiopici diretti contro anticorpi anti-tnf.
NO985281D0 (no) Monoklonalt antihumant MP52-antistoff
EP1106701A4 (en) MONOCLONAL ANTIBODY DIRECTED AGAINST DYNAMIC TRYPSIN
BR1100504A (pt) anticorpos anti-ige.
AU2001254858A1 (en) Anti-D monoclonal antibodies
AUPP259798A0 (en) Monoclonal antibody against hb-egf